Jove
Visualize
Contact Us

Related Concept Videos

Cardiomyopathy I: Introduction and Classification01:25

Cardiomyopathy I: Introduction and Classification

645
Cardiomyopathy, or CMP, is a group of diseases affecting the myocardial structure, impairing its ability to pump blood effectively. This condition can lead to arrhythmias, heart failure, or sudden cardiac death.Cardiomyopathies are classified into primary and secondary categories:Primary Cardiomyopathy refers to conditions involving only the heart muscle that are often idiopathic (of unknown cause) or genetic. They primarily affect the myocardium without the involvement of other systemic...
645
Cardiomyopathy II: Dilated Cardiomyopathy01:30

Cardiomyopathy II: Dilated Cardiomyopathy

622
Dilated cardiomyopathy, or DCM, is a progressive myocardial disorder characterized by ventricular chamber dilation and contractile dysfunction.EtiologyVarious factors can cause DCM, including hypertension and heavy alcohol intake, which contribute to the weakening and enlargement of the heart muscle. Viral infections, such as Coxsackievirus B, adenoviruses, and influenza, can lead to DCM by causing inflammation and damage to heart tissue. Certain chemotherapeutic agents, including daunorubicin,...
622
Cardiomyopathy IV: Restrictive Cardiomyopathy01:29

Cardiomyopathy IV: Restrictive Cardiomyopathy

617
Restrictive cardiomyopathy (RCM) is a rare heart muscle disease characterized by impaired ventricular filling due to stiffened ventricular walls, leading to significant diastolic dysfunction.EtiologyRestrictive cardiomyopathy can arise from both inherited and acquired diseases, many of which are systemic. It is categorized into four main types: infiltrative, storage, non-infiltrative, and endomyocardial diseases.Infiltrative diseases, such as amyloidosis, lead to RCM by depositing amyloid...
617
Cardiomyopathy III: Hypertrophic Cardiomyopathy01:29

Cardiomyopathy III: Hypertrophic Cardiomyopathy

540
Hypertrophic cardiomyopathy, or HCM, is an autosomal dominant genetic disorder characterized by asymmetric left ventricular hypertrophy without ventricular dilation. It is more common in men and is typically diagnosed in young, athletic adults.EtiologyHCM is primarily genetic and is caused by mutations in genes encoding sarcomeric proteins. Researchers have identified over 1400 mutations across at least 11 different genes. Among these, the most frequently occurring mutations are found in the...
540
Cardiomyopathy V: Interprofessional Care01:29

Cardiomyopathy V: Interprofessional Care

493
Managing cardiomyopathy involves addressing underlying or precipitating causes, treating heart failure with medications, and implementing dietary changes and a balanced exercise and rest regimen.Lifestyle ModificationsCardiomyopathy patients should adopt a low-sodium diet to reduce fluid retention and manage heart failure. A personalized exercise and rest plan helps maintain physical fitness without overstraining the heart. Avoiding alcohol and tobacco is essential to prevent further damage to...
493
Myocarditis I: Introduction01:21

Myocarditis I: Introduction

460
Myocarditis is inflammation of the myocardium, which is the muscular layer of the heart.EtiologyMyocarditis has a diverse etiology, including a wide range of infectious and non-infectious causes:Infectious CausesViral: Common viruses include Coxsackie A and B, adenovirus, parvovirus B19, enteroviruses, and influenza A.Bacterial: Examples include infections caused by Streptococcus, Staphylococcus, and Mycoplasma species.Rickettsial: Infections like Rocky Mountain spotted fever can result in...
460

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

New images in carcinoid heart disease.

Cardiovascular journal of Africa·2012
Same author

Diagnostic accuracy of transesophageal echocardiography for detection of atrial masses.

Acta medica Croatica : casopis Hravatske akademije medicinskih znanosti·2001
Same author

Pilocarpine in the prevention of postirradiation xerostomia.

Acta medica Croatica : casopis Hravatske akademije medicinskih znanosti·2000
Same author

Clinical interpretation of brainstem evoked response audiometry abnormalities in cochlear pathology.

Acta medica Croatica : casopis Hravatske akademije medicinskih znanosti·2000
Same author

Clinical and echocardiographic features of two large left atrial parietal thrombi.

Acta medica Croatica : casopis Hravatske akademije medicinskih znanosti·1999
Same author

Vertigo as a prognostic factor in sudden hearing loss.

Acta medica Croatica : casopis Hravatske akademije medicinskih znanosti·1998
Same journal

[CHARACTERISTIC FEATURES OF PRESSURE ULCER INFECTION].

Acta medica Croatica : casopis Hravatske akademije medicinskih znanosti·2017
Same journal

[PERSONALIZED APPROACH TO PATIENT WITH CHRONIC WOUND IN FAMILY MEDICINE].

Acta medica Croatica : casopis Hravatske akademije medicinskih znanosti·2017
Same journal

[APPLICATION OF TOPICAL HEMOGLOBIN SPRAY IN INFECTED POSTTRAUMATIC AND POSTOPERATIVE WOUNDS].

Acta medica Croatica : casopis Hravatske akademije medicinskih znanosti·2017
Same journal

[APPLICATION OF NEGATIVE PRESSURE THERAPY].

Acta medica Croatica : casopis Hravatske akademije medicinskih znanosti·2017
Same journal

[PATIENTS WITH PRESSURE ULCERS IN THE UNIFIED EMERGENCY ADMISSION DEPARTMENT – OUR REALITY].

Acta medica Croatica : casopis Hravatske akademije medicinskih znanosti·2017
Same journal

[Proposition of algorhythm for treatment with hyperbaric oxygenation Hyperbaric oxygenation in Rijeka Clinical Hospital Center].

Acta medica Croatica : casopis Hravatske akademije medicinskih znanosti·2017
See all related articles
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Video

Updated: Feb 20, 2026

Tachycardia-Induced Cardiomyopathy As a Chronic Heart Failure Model in Swine
10:08

Tachycardia-Induced Cardiomyopathy As a Chronic Heart Failure Model in Swine

Published on: February 17, 2018

14.0K

[SEPTIC CARDIOMYOPATHY].

J Vincelj

    Acta Medica Croatica : Casopis Hravatske Akademije Medicinskih Znanosti
    |October 28, 2017
    PubMed
    Summary
    This summary is machine-generated.

    Septic cardiomyopathy, or sepsis-induced myocardial dysfunction (SIMD), affects over 40% of sepsis patients. This reversible condition significantly increases mortality, highlighting the urgent need for effective treatments.

    More Related Videos

    An Intact Pericardium Ischemic Rodent Model
    07:15

    An Intact Pericardium Ischemic Rodent Model

    Published on: September 2, 2021

    3.1K
    Author Spotlight: Advanced Integrated Model for Sepsis-Induced Myopathy and Single-Cell Metabolic Analysis
    04:01

    Author Spotlight: Advanced Integrated Model for Sepsis-Induced Myopathy and Single-Cell Metabolic Analysis

    Published on: June 14, 2024

    1.5K

    Related Experiment Videos

    Last Updated: Feb 20, 2026

    Tachycardia-Induced Cardiomyopathy As a Chronic Heart Failure Model in Swine
    10:08

    Tachycardia-Induced Cardiomyopathy As a Chronic Heart Failure Model in Swine

    Published on: February 17, 2018

    14.0K
    An Intact Pericardium Ischemic Rodent Model
    07:15

    An Intact Pericardium Ischemic Rodent Model

    Published on: September 2, 2021

    3.1K
    Author Spotlight: Advanced Integrated Model for Sepsis-Induced Myopathy and Single-Cell Metabolic Analysis
    04:01

    Author Spotlight: Advanced Integrated Model for Sepsis-Induced Myopathy and Single-Cell Metabolic Analysis

    Published on: June 14, 2024

    1.5K

    Area of Science:

    • Cardiology
    • Critical Care Medicine
    • Pathophysiology

    Background:

    • Septic cardiomyopathy, a reversible myocardial dysfunction, is prevalent in over 40% of severe sepsis or septic shock patients.
    • Sepsis-induced myocardial dysfunction (SIMD) is a key predictor of poor outcomes, with mortality rates of 70%-90% in affected patients.
    • SIMD presents as ventricular dilatation, reduced ejection fraction, and diminished responsiveness to fluids and catecholamines, typically reversing within 7-10 days.

    Purpose of the Study:

    • To review the mechanisms, diagnosis, and management of septic cardiomyopathy.
    • To emphasize the significant impact of SIMD on patient mortality and outcomes.
    • To discuss current therapeutic strategies and the lack of efficient treatments.

    Main Methods:

    • Review of existing literature on septic cardiomyopathy and sepsis-induced myocardial dysfunction.
    • Analysis of diagnostic methods including hemodynamic monitoring, ECG, echocardiography, and laboratory tests.
    • Examination of therapeutic interventions such as infection control, fluid resuscitation, inotropic agents, and supportive care.

    Main Results:

    • Septic cardiomyopathy is characterized by impaired myocardial contractility due to disrupted intracellular-extracellular matrix communication.
    • Diagnostic work-up involves a combination of clinical monitoring, imaging, and laboratory investigations.
    • Current management includes infection control, hemodynamic optimization, and supportive measures, but no specific efficient therapy exists.

    Conclusions:

    • Septic cardiomyopathy is a critical complication of sepsis with high mortality.
    • Early diagnosis and comprehensive management are essential, though effective targeted therapies are still lacking.
    • Further research is needed to develop efficient treatments for septic cardiomyopathy.